financetom
Business
financetom
/
Business
/
Why Did AbCellera's Stock Jump Over 7% After Hours?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Did AbCellera's Stock Jump Over 7% After Hours?
Mar 10, 2026 8:33 PM

AbCellera Biologics Inc. ( ABCL ) shares are trading on Thursday.

Check out the current price of ABCL stock here.

After-Hours Trading Activity

Shares of the biotechnology company climbed by 7.72% during after-hours trading, reaching $6.42 on Wednesday.

This followed an 18.49% increase during regular trading, where the stock closed at $5.96, according to Benzinga Pro data. The after-hours price added $0.46 to the $0.93 gain seen during the regular session.

Q3 Earnings Scheduled

AbCellera is set to announce its third-quarter financial results on November 6 at 5:00 p.m. Eastern Time. Analysts are projecting an earnings per share (EPS) of -$0.17 and revenue of $6.45 million for the quarter.

See Also: Rick Perry-Backed Fermi Stock Surges 9% After Hours After Making Nasdaq Debut: What You Should Know

Leadership Appointment

Dr. Sarah Noonberg was appointed as the new Chief Medical Officer of the British Columbia-based company on September 10. With over 20 years of experience in the industry, Dr. Noonberg brings deep expertise in oncology, neuroscience, rare diseases, gene therapy, and cell therapy.

She is also known for her work on enzalutamide, a treatment for prostate cancer.

Q2 Financial Performance

AbCellera reported its second-quarter earnings on August 7, posting an actual EPS of -$0.12, which was better than the estimated EPS of -$0.17, beating expectations by 29.4%.

The company's revenue for the quarter came in at $17.08 million, far surpassing the estimated $6.58 million and exceeding projections by 159.5%.

Market Position

Over the past year, shares of the clinical-stage company have surged by 140.32%, trading between $1.89 and $5.97 within the 52-week range. The company now holds a market capitalization of $1.78 billion, with an average trading volume of 4.36 million shares.

With a strong Momentum in the 94th percentile, Benzinga’s Edge Stock Rankings indicate that ABCL has a positive price trend across all time frames. See how its progress compares to other big companies.

Read Next:

Why Are Concorde International Group Shares Soaring 80% After Hours?

Image via Shutterstock/ Volha_R

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
May 14, 2026
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration BOSTON, May 14, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced that the German-based but globally active CHEPLAPHARM Group, a world leader in the acquisition of original preparations from the research-based pharmaceutical industry, is going live on the TraceLink...
Form 8.3
Form 8.3
May 14, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Fiserv Issues Medium-Term Financial Outlook Through 2029
Fiserv Issues Medium-Term Financial Outlook Through 2029
May 14, 2026
09:17 AM EDT, 05/14/2026 (MT Newswires) -- Fiserv ( FISV ) issued Thursday its medium-term financial outlook and said it expects adjusted earnings per share to grow in the double-digit range for 2027 to 2029. Adjusted earnings are expected to exceed $12 by 2029. Four analysts polled by FactSet expect $12.64. The company also projected adjusted revenue to grow 4%...
Sabre Prices $150 Million Exchangeable Senior Notes Offering
Sabre Prices $150 Million Exchangeable Senior Notes Offering
May 14, 2026
09:16 AM EDT, 05/14/2026 (MT Newswires) -- Sabre (SABR) said Thursday its unit, Sabre GLBL, issued $150 million in 7% exchangeable senior notes due 2031. The debt matures May 15, 2031, and proceeds will be used to repurchase $100 million of outstanding 7.32% notes due 2026, the company said. The notes are fully guaranteed by the parent and another unit,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved